NervGen Pharma Corp. NGEN
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 61.12M | 11.86M | 16.10M | 8.16M | 11.49M |
| Total Receivables | 141.00K | 67.00K | 65.10K | 271.00K | 113.40K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.83M | 2.03M | 287.10K | 161.00K | 93.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 160.50K | 633.30K | 180.90K | 494.40K | 388.50K |
| Total Current Assets | 63.24M | 14.59M | 16.63M | 9.09M | 12.09M |
|
|
|||||
| Total Current Assets | 63.24M | 14.59M | 16.63M | 9.09M | 12.09M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 268.50K | 283.10K | 298.40K | 303.80K | 320.50K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 63.51M | 14.88M | 16.93M | 9.39M | 12.41M |
|
|
|||||
| Total Accounts Payable | 20.80K | 30.00K | 20.00K | 27.90K | 28.70K |
| Total Accrued Expenses | 3.00M | 4.18M | 3.38M | 3.85M | 3.80M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 6.10K | 23.90K | 42.30K |
| Total Finance Division Other Current Liabilities | 27.51M | 6.70M | 10.99M | 7.60M | 9.21M |
| Total Other Current Liabilities | 27.51M | 6.70M | 10.99M | 7.60M | 9.21M |
| Total Current Liabilities | 30.53M | 10.91M | 14.39M | 11.50M | 13.08M |
|
|
|||||
| Total Current Liabilities | 30.53M | 10.91M | 14.39M | 11.50M | 13.08M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 30.53M | 10.91M | 14.39M | 11.50M | 13.08M |
|
|
|||||
| Common Stock & APIC | 98.97M | 77.30M | 75.12M | 64.96M | 64.83M |
| Retained Earnings | -93.86M | -106.34M | -107.04M | -86.05M | -84.47M |
| Treasury Stock & Other | 27.87M | 33.02M | 34.45M | 18.97M | 18.97M |
| Total Common Equity | 32.98M | 3.97M | 2.54M | -2.11M | -673.40K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 32.98M | 3.97M | 2.54M | -2.11M | -673.40K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 32.98M | 3.97M | 2.54M | -2.11M | -673.40K |
|
|
|||||